Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Elekta

56.80 SEK

+1.70 %

Less than 1K followers

EKTA B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+1.70 %
+22.10 %
+28.22 %
+13.69 %
-7.11 %
-8.90 %
-8.21 %
-48.18 %
+551.12 %

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Read more
Market cap
21.79B SEK
Turnover
58.28M SEK
Revenue
18.02B
EBIT %
4.94 %
P/E
91.61
Dividend yield-%
4.23 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/3
2026

Interim report Q3'26

5/3
2026

Half year dividend

28/5
2026

Annual report '26

All
Press releases
ShowingAll content types
Regulatory press release11/26/2025, 6:30 AM

Andra kvartalet, augusti–oktober 2025/26

Elekta
Regulatory press release11/26/2025, 6:30 AM

Second quarter, August–October 2025/26

Elekta
Press release11/12/2025, 6:30 AM

Inbjudan till presentation av Elektas andra kvartal 2025/26

Elekta

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/12/2025, 6:30 AM

Invitation to the presentation of Elekta’s second quarter 2025/26

Elekta
Regulatory press release10/31/2025, 6:30 AM

Elektas valberedning inför årsstämman 2026

Elekta
Regulatory press release10/31/2025, 6:30 AM

Elekta’s Nomination Committee for the Annual General Meeting 2026

Elekta
Press release10/9/2025, 5:30 AM

New impact report reveals radiotherapy’s role in cancer care

Elekta
Press release10/9/2025, 5:30 AM

Ny påverkansrapport belyser strålbehandlingens roll inom cancervården

Elekta
Regulatory press release9/29/2025, 6:18 PM

Finansinspektionen: Flaggningsmeddelande i Elekta AB (publ)

Elekta
Press release9/29/2025, 6:10 PM

Studie visar att MRI-styrd adaptiv strålbehandling med Elekta Unity förbättrar patientrapporterade urinvägssymtom hos män med prostatacancer

Elekta
Press release9/29/2025, 6:10 PM

Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer

Elekta
Regulatory press release9/26/2025, 1:27 PM

Finansinspektionen: Flaggningsmeddelande i Elekta AB (publ)

Elekta
Press release9/25/2025, 5:30 AM

Elekta uppmärksammar den tvåmiljonte patienten som behandlats med Leksell Gamma Knife strålbehandling

Elekta
Press release9/25/2025, 5:30 AM

Elekta marks two millionth patient treated with Leksell Gamma Knife radiosurgery

Elekta
Regulatory press release9/8/2025, 5:30 AM

Elekta tillkännager förändringar i koncernledningen

Elekta
Regulatory press release9/8/2025, 5:30 AM

Elekta announces changes in Executive Management

Elekta
Regulatory press release9/4/2025, 2:56 PM

Kommuniké från Elektas årsstämma 2025

Elekta
Regulatory press release9/4/2025, 2:56 PM

Report from the Annual General Meeting 2025 of Elekta

Elekta
Regulatory press release8/28/2025, 5:30 AM

Delårsrapport, Första kvartalet maj–juli 2025/26

Elekta
Regulatory press release8/28/2025, 5:30 AM

Interim report, First quarter May–July 2025/26

Elekta
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.